Huihong Xu, MD

Clinical Associate Professor, Pathology & Laboratory Medicine

Huihong Xu
670 Albany St Biosquare III


Huihong Xu, MD is an Assistant Professor of Pathology & Laboratory Medicine at the Chobanian and Avedisian School of Medicine and Chief Pathologist in Anatomic and Clinical Pathology at the Lemuel Shattuck Hospital. At BUSM she is also a previous teaching fellow and a current lab instructor of gross pathology and teaching instructor of general pathology. In her career, she is a two time Chief Resident and Excellent Student of the Year. For the past six years she has been Chief of Anatomic Pathology at Lemuel Shattuck Hospital. Dr. Xu has given numerous presentations and written many articles and abstracts, but she is perhaps most notable for her extensive involvement on six different medical committees including the Committee on Admission at BUSM.

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
  • VA Boston Healthcare System



  • Fudan University, MD
  • University of Massachusetts Boston, MS


  • Published on 2/6/2023

    Burns L, Naimi B, Ronan M, Xu H, Weber HC. Report of a Novel Molecular Profile in Malignant Insulinoma. J Clin Med. 2023 Feb 06; 12(4). PMID: 36835815.

    Read at: PubMed
  • Published on 8/1/2022

    Xu H, Fan F, Gong Y, Jing X, Lin X, Wang H, Lin F, Li Z. Diagnostic Challenges in Fine-Needle Aspiration Cytology of Mediastinal Tumors and Lesions. Arch Pathol Lab Med. 2022 08 01; 146(8):960-974. PMID: 34402861.

    Read at: PubMed
  • Published on 7/18/2022

    Li Z, Xu H, Fan F. Approach to Mediastinal Fine Needle Aspiration Cytology. Adv Anat Pathol. 2022 Nov 01; 29(6):337-348. PMID: 35838636.

    Read at: PubMed
  • Published on 3/31/2022

    Pan K, Farrukh H, Chittepu VCSR, Xu H, Pan CX, Zhu Z. CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy. J Exp Clin Cancer Res. 2022 Mar 31; 41(1):119. PMID: 35361234.

    Read at: PubMed
  • Published on 12/24/2018

    Xu H, Bratton L, Nead M, Russell D, Zhou Z. Comparison of programmed death-ligand 1 (PD-L1) immunostain for nonsmall cell lung carcinoma between paired cytological and surgical specimens. Cytojournal. 2018; 15:29. PMID: 30662515.

    Read at: PubMed
  • Published on 6/1/2018

    Ho RX, Meyer RD, Chandler KB, Ersoy E, Park M, Bondzie PA, Rahimi N, Xu H, Costello CE, Rahimi N. MINAR1 is a Notch2-binding protein that inhibits angiogenesis and breast cancer growth. J Mol Cell Biol. 2018 06 01; 10(3):195-204. PMID: 29329397.

    Read at: PubMed
  • Published on 8/7/2016

    Xu H, Remick DG. Pathology: A Satisfying Medical Profession. Acad Pathol. 2016 Jan-Dec; 3:2374289516661559. PMID: 28725775.

    Read at: PubMed
  • Published on 7/1/2015

    Fujita A, Xu H, Chang YM, Jalisi S, Sakai O. Malignant Mixed Tumor of the Hard Palate. Radiographics. 2015 Jul-Aug; 35(4):1186-90. PMID: 26172359.

    Read at: PubMed
  • Published on 1/6/2015

    The I, Ruijtenberg S, Bouchet BP, Cristobal A, Prinsen MB, van Mourik T, Koreth J, Xu H, Heck AJ, Akhmanova A, Cuppen E, Boxem M, Muñoz J, van den Heuvel S. Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells. Nat Commun. 2015 Jan 06; 6:5906. PMID: 25562820.

    Read at: PubMed
  • Published on 5/10/2011

    Xu H, Cao B, George A, Mao C. Self-assembly and mineralization of genetically modifiable biological nanofibers driven by ß-structure formation. Biomacromolecules. 2011 Jun 13; 12(6):2193-9. PMID: 21520924.

    Read at: PubMed

View 5 more publications: View full profile at BUMC

View all profiles